WP-1303

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameWP-1303
Drug Alias NameH-1129WP-1303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesD. Western Therapeutics Institute
China Registration ClassN/A

Develop Information

Active CompaniesD Western Therapeutics Institute IncWakamotoD. Western Therapeutics Institute
Inactive CompaniesN/A
Active IndicationsGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A